Tirzepatide vs Semaglutide:
Body Composition Comparison 2026

Tirzepatide shows higher average weight loss at 22.5% compared to 15%. However, more weight loss doesn't always mean better results — what matters is whether that weight is fat or muscle.

Both medications carry a moderate muscle loss risk. Without a proper resistance training and protein protocol, up to 40% of weight lost on either drug could be lean muscle tissue.

The best choice depends on your specific goals, insurance coverage, and how your body responds. Either way, protecting your muscle mass requires deliberate effort beyond the medication itself.

Both Tirzepatide and Semaglutide share common GLP-1 side effects including nausea, constipation, and appetite suppression. The side effects most relevant to body composition are:

• Muscle loss — Both carry moderate risk without proper protein intake and resistance training
• Fatigue and weakness — Common during caloric deficit, worsened by muscle loss
• Nausea — Can make it harder to consume adequate protein, especially early in treatment
• Hair loss — Telogen effluvium from rapid weight loss, not the drug itself

The key difference: Tirzepatide works as a GLP-1/GIP dual receptor agonist while Semaglutide is a GLP-1 receptor agonist. This can affect how your body responds and which side effects are more prominent.